Amer Renal Assoc Hldg is a diagnostics & research business based in the US. Amer Renal Assoc Hldg shares (ARA) are listed on the NYSE and all prices are listed in US Dollars. Amer Renal Assoc Hldg employs 4,977 staff and has a trailing 12-month revenue of around $814.1 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| 52-week range | $0.00 - $0.00 |
|---|---|
| 50-day moving average | $11.47 |
| 200-day moving average | $9.70 |
| Wall St. target price | $10.00 |
| PE ratio | N/A |
| Dividend yield | $1.3 (11.3%) |
| Earnings per share (TTM) | $-0.67 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Amer Renal Assoc Hldg stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Amer Renal Assoc Hldg's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Amer Renal Assoc Hldg's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.24. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Amer Renal Assoc Hldg's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Amer Renal Assoc Hldg's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $113.5 million.
The EBITDA is a measure of a Amer Renal Assoc Hldg's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $814.1 million |
|---|---|
| Operating margin TTM | 9.73% |
| Gross profit TTM | $254.5 million |
| Return on assets TTM | 4.35% |
| Return on equity TTM | 17.51% |
| Profit margin | -1.11% |
| Book value | $-2.50 |
| Market Capitalization | $397.9 million |
TTM: trailing 12 months
We're not expecting Amer Renal Assoc Hldg to pay a dividend over the next 12 months.
Over the last 12 months, Amer Renal Assoc Hldg's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Amer Renal Assoc Hldg's is 1.1062. This would suggest that Amer Renal Assoc Hldg's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
American Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States. It operates dialysis clinics focusing on joint venture partnerships with physicians. The company offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease. As of December 31, 2019, it operated 246 dialysis clinics in partnership with 400 nephrologist partners treating approximately 17,300 patients in 27 states and the District of Columbia. The company was founded in 1999 and is headquartered in Beverly, Massachusetts. .
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
The best platforms to use for automatic investing include Wealthfront, SoFi, Schwab, Vanguard, Titan, Acorns and more. See our full list here.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
5 Betterment robo-advisor alternatives to consider when building your portfolio.
What you need to know about investing in the leading indicator for the overall US stock market.
How do you gift stocks to loved ones? Learn the ins and outs of finding the right investments for them.
Check out the best-performing ETFs so far in 2024.
Acorns is a financial service that rounds up your purchases and turns the extra change into investments.